1. Home
  2. LYEL
  3. LYEL News

Latest Lyell Immunopharma Inc. (LYEL) News on November 27, 2025

LYEL

Associated Press Finance

14 days ago

Lyell Immunopharma: Q3 Earnings Snapshot

Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2025
LYEL

GlobeNewswire

14 days ago

Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2025

Metagenomi, Ovid CEOs step aside; Cogent soars on ‘unprecedented’ stomach cancer data
LYEL

BioPharma Dive

15 days ago

Metagenomi, Ovid CEOs step aside; Cogent soars on ‘unprecedented’ stomach cancer data

Lyell acquires worldwide rights from ICT to CAR T-cell therapy
LYEL

Pharmaceutical Technology

16 days ago

Lyell acquires worldwide rights from ICT to CAR T-cell therapy

LYEL

MT Newswires

16 days ago

Lyell Immunopharma Acquires Global Rights to CAR T-Cell Product Candidate for Colorectal Cancer

Lyell Immunopharma Acquires Exclusive Global Rights to a Next-Generation CAR T-Cell Product Candidate in Clinical Development for Metastatic Colorectal Cancer
LYEL

GlobeNewswire

17 days ago

Lyell Immunopharma Acquires Exclusive Global Rights to a Next-Generation CAR T-Cell Product Candidate in Clinical Development for Metastatic Colorectal Cancer

Lyell Announces Two Oral Presentations from the Phase 1/2 Clinical Trial of Ronde-Cel for the Treatment of Aggressive Large B-Cell Lymphoma at the 67th ASH Annual Meeting and Exposition
LYEL

GlobeNewswire

24 days ago

Lyell Announces Two Oral Presentations from the Phase 1/2 Clinical Trial of Ronde-Cel for the Treatment of Aggressive Large B-Cell Lymphoma at the 67th ASH Annual Meeting and Exposition

Lyell Immunopharma to Participate in the H.C. Wainwright “HCW@Home” Series
LYEL

GlobeNewswire

5 months ago

Lyell Immunopharma to Participate in the H.C. Wainwright “HCW@Home” Series

Lyell reports new clinical data from trial of large B-cell lymphoma therapy
LYEL

Clinical Trials Arena

5 months ago

Lyell reports new clinical data from trial of large B-cell lymphoma therapy

LYEL

MT Newswires

5 months ago

Lyell Immunopharma Says LYL314 Shows 'Robust' Responses in Large B-Cell Lymphoma Trial

Lyell Immunopharma Announces Positive New Clinical Data Demonstrating High Rates of Durable Complete Responses from the Phase 1/2 Trial of LYL314 for the Treatment of Aggressive Large B-cell Lymphoma
LYEL

GlobeNewswire

5 months ago

Lyell Immunopharma Announces Positive New Clinical Data Demonstrating High Rates of Durable Complete Responses from the Phase 1/2 Trial of LYL314 for the Treatment of Aggressive Large B-cell Lymphoma

Lyell Immunopharma Strengthens Clinical and Commercial Capabilities with Key Board and Executive Appointments
LYEL

GlobeNewswire

6 months ago

Lyell Immunopharma Strengthens Clinical and Commercial Capabilities with Key Board and Executive Appointments

Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
LYEL

GlobeNewswire

6 months ago

Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference

LYEL

Associated Press Finance

6 months ago

Lyell Immunopharma: Q1 Earnings Snapshot

Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2025
LYEL

GlobeNewswire

6 months ago

Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2025

Lyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of LYL314 for the Treatment of Large B-cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) 2025
LYEL

GlobeNewswire

7 months ago

Lyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of LYL314 for the Treatment of Large B-cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) 2025

LYEL

MT Newswires

7 months ago

Lyell Immunopharma Says its Relapsed Large B-Cell Lymphoma Therapy Receives US FDA's REMAT Designation

Lyell Immunopharma Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for LYL314 for the Treatment of Relapsed and/or Refractory Large B-Cell Lymphoma
LYEL

GlobeNewswire

7 months ago

Lyell Immunopharma Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for LYL314 for the Treatment of Relapsed and/or Refractory Large B-Cell Lymphoma

Is Lyell Immunopharma, Inc. (LYEL) the Cheapest Stock Insiders Are Buying In March?
LYEL

Insider Monkey

8 months ago

Is Lyell Immunopharma, Inc. (LYEL) the Cheapest Stock Insiders Are Buying In March?

Favourable Signals For Lyell Immunopharma: Numerous Insiders Acquired Stock
LYEL

Simply Wall St.

8 months ago

Favourable Signals For Lyell Immunopharma: Numerous Insiders Acquired Stock

Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2024
LYEL

GlobeNewswire

9 months ago

Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2024

Lyell Immunopharma Announces Participation in Upcoming Investor Conferences
LYEL

GlobeNewswire

9 months ago

Lyell Immunopharma Announces Participation in Upcoming Investor Conferences

Lyell Immunopharma, Inc. (NASDAQ:LYEL) has caught the attention of institutional investors who hold a sizeable 46% stake
LYEL

Simply Wall St.

10 months ago

Lyell Immunopharma, Inc. (NASDAQ:LYEL) has caught the attention of institutional investors who hold a sizeable 46% stake

Lyell Immunopharma (LYEL) Upgraded to Strong Buy: Here's Why
LYEL

Zacks

10 months ago

Lyell Immunopharma (LYEL) Upgraded to Strong Buy: Here's Why

Lyell to Highlight Vision for its Next-Generation CAR T-Cell Therapy Pipeline at 43rd Annual JP Morgan Healthcare Conference
LYEL

GlobeNewswire

a year ago

Lyell to Highlight Vision for its Next-Generation CAR T-Cell Therapy Pipeline at 43rd Annual JP Morgan Healthcare Conference

After Plunging -37.9% in 4 Weeks, Here's Why the Trend Might Reverse for Lyell Immunopharma (LYEL)
LYEL

Zacks

a year ago

After Plunging -37.9% in 4 Weeks, Here's Why the Trend Might Reverse for Lyell Immunopharma (LYEL)

After Plunging -31.22% in 4 Weeks, Here's Why the Trend Might Reverse for Lyell Immunopharma (LYEL)
LYEL

Zacks

a year ago

After Plunging -31.22% in 4 Weeks, Here's Why the Trend Might Reverse for Lyell Immunopharma (LYEL)

Down -30.89% in 4 Weeks, Here's Why Lyell Immunopharma (LYEL) Looks Ripe for a Turnaround
LYEL

Zacks

a year ago

Down -30.89% in 4 Weeks, Here's Why Lyell Immunopharma (LYEL) Looks Ripe for a Turnaround

Lyell Presents Positive Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the Treatment of B-cell Lymphoma at the 2024 ASH Annual Meeting
LYEL

GlobeNewswire

a year ago

Lyell Presents Positive Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the Treatment of B-cell Lymphoma at the 2024 ASH Annual Meeting

Lyell Immunopharma (LYEL) Upgraded to Buy: Here's What You Should Know
LYEL

Zacks

a year ago

Lyell Immunopharma (LYEL) Upgraded to Buy: Here's What You Should Know

LYEL

Associated Press Finance

a year ago

Lyell Immunopharma: Q3 Earnings Snapshot

Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2024
LYEL

GlobeNewswire

a year ago

Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2024

Lyell Announces Presentation of Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the treatment of B-cell Lymphoma at the 2024 American Society of Hematology (ASH) Annual Meeting
LYEL

GlobeNewswire

a year ago

Lyell Announces Presentation of Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the treatment of B-cell Lymphoma at the 2024 American Society of Hematology (ASH) Annual Meeting

LiveOne Leads The Pack Of 3 US Penny Stocks
LYEL

Simply Wall St.

a year ago

LiveOne Leads The Pack Of 3 US Penny Stocks

Lyell Immunopharma Completes Acquisition of ImmPACT Bio
LYEL

GlobeNewswire

a year ago

Lyell Immunopharma Completes Acquisition of ImmPACT Bio

LYEL

MT Newswires

a year ago

Lyell Immunopharma Shares Fall After BofA Downgrade

LYEL

Investing.com

a year ago

Lyell shares down as BofA double downgrades to Sell

Lyell goes all in on CAR-T therapies, buys ImmPACT Bio and trims pipeline
LYEL

Pharmaceutical Technology

a year ago

Lyell goes all in on CAR-T therapies, buys ImmPACT Bio and trims pipeline

Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies
LYEL

GlobeNewswire

a year ago

Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies

Lyell, in search of a turnaround, to buy cell therapy startup ImmPact
LYEL

BioPharma Dive

a year ago

Lyell, in search of a turnaround, to buy cell therapy startup ImmPact

Lyell Immunopharma Announces the Acceptance Abstracts for Presentation at 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
LYEL

GlobeNewswire

a year ago

Lyell Immunopharma Announces the Acceptance Abstracts for Presentation at 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Lyell Immunopharma Announces Participation in Goldman Sachs Cell Therapy Day
LYEL

GlobeNewswire

a year ago

Lyell Immunopharma Announces Participation in Goldman Sachs Cell Therapy Day

Lyell Immunopharma Announces Participation in September Investor Conferences
LYEL

GlobeNewswire

a year ago

Lyell Immunopharma Announces Participation in September Investor Conferences

Recent uptick might appease Lyell Immunopharma, Inc. (NASDAQ:LYEL) institutional owners after losing 32% over the past year
LYEL

Simply Wall St.

a year ago

Recent uptick might appease Lyell Immunopharma, Inc. (NASDAQ:LYEL) institutional owners after losing 32% over the past year

LYEL

MT Newswires

a year ago

Caribou Biosciences Names Tina Albertson as Chief Medical Officer

LYEL

Associated Press Finance

a year ago

Lyell Immunopharma: Q2 Earnings Snapshot

Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2024
LYEL

GlobeNewswire

a year ago

Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2024

Lyell Immunopharma Shares Plunge On One Patient Death In CAR-T Cell Therapy Cancer Trial
LYEL

Benzinga

a year ago

Lyell Immunopharma Shares Plunge On One Patient Death In CAR-T Cell Therapy Cancer Trial

Lyell Immunopharma Reports Dose-dependent Clinical Activity from Phase 1 Trial of LYL797, a ROR1-targeted CAR-T Cell Product Candidate Enhanced with its Proprietary Anti-exhaustion Technology
LYEL

GlobeNewswire

a year ago

Lyell Immunopharma Reports Dose-dependent Clinical Activity from Phase 1 Trial of LYL797, a ROR1-targeted CAR-T Cell Product Candidate Enhanced with its Proprietary Anti-exhaustion Technology

Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
LYEL

GlobeNewswire

a year ago

Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference

Lyell Immunopharma to Participate in BofA Securities Health Care Conference
LYEL

GlobeNewswire

2 years ago

Lyell Immunopharma to Participate in BofA Securities Health Care Conference

Lyell Immunopharma First Quarter 2024 Earnings: US$0.24 loss per share (vs US$0.27 loss in 1Q 2023)
LYEL

Simply Wall St.

2 years ago

Lyell Immunopharma First Quarter 2024 Earnings: US$0.24 loss per share (vs US$0.27 loss in 1Q 2023)

LYEL

MT Newswires

2 years ago

Lyell Immunopharma Shares Rise After Q1 Net Loss Narrows

LYEL

Associated Press Finance

2 years ago

Lyell Immunopharma: Q1 Earnings Snapshot

Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024
LYEL

GlobeNewswire

2 years ago

Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024

Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) market cap decline of US$89m may not have as much of an impact on institutional owners after a year of 1.4% returns
LYEL

Simply Wall St.

2 years ago

Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) market cap decline of US$89m may not have as much of an impact on institutional owners after a year of 1.4% returns

Lyell Immunopharma (LYEL) Is Up 28.45% in One Week: What You Should Know
LYEL

Zacks

2 years ago

Lyell Immunopharma (LYEL) Is Up 28.45% in One Week: What You Should Know

Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meeting
LYEL

GlobeNewswire

2 years ago

Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meeting

Lyell Immunopharma Inc (LYEL) Reports 2023 Financial Results and Business Highlights
LYEL

GuruFocus.com

2 years ago

Lyell Immunopharma Inc (LYEL) Reports 2023 Financial Results and Business Highlights

Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023
LYEL

GlobeNewswire

2 years ago

Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023

Lyell Immunopharma Announces Participation in March Investor Conferences
LYEL

GlobeNewswire

2 years ago

Lyell Immunopharma Announces Participation in March Investor Conferences

Pitney Bowes (PBI) Beats Q4 Earnings and Revenue Estimates
LYEL

Zacks

2 years ago

Pitney Bowes (PBI) Beats Q4 Earnings and Revenue Estimates

Profound Medical (PROF) Soars 9.4%: Is Further Upside Left in the Stock?
LYEL

Zacks

2 years ago

Profound Medical (PROF) Soars 9.4%: Is Further Upside Left in the Stock?

Cronos’ Spinach® Brand Ends 2023 as the Number One Flower Brand in Canada1
LYEL

GlobeNewswire

2 years ago

Cronos’ Spinach® Brand Ends 2023 as the Number One Flower Brand in Canada1

EV Roundup: STLA Unveils Electrified Platform, FSR Faces NHTSA Scrutiny & More
LYEL

Zacks

2 years ago

EV Roundup: STLA Unveils Electrified Platform, FSR Faces NHTSA Scrutiny & More

Gogoro to Announce Fourth Quarter and Full Year 2023 Financial Results on February 7th at 7 a.m. Eastern Time
LYEL

PR Newswire

2 years ago

Gogoro to Announce Fourth Quarter and Full Year 2023 Financial Results on February 7th at 7 a.m. Eastern Time

SunOpta (STKL) Stock Dips While Market Gains: Key Facts
LYEL

Zacks

2 years ago

SunOpta (STKL) Stock Dips While Market Gains: Key Facts

LYEL

Business Wire

2 years ago

Mitek Announces Extension of Nasdaq Stay and Hearing Date

Modivcare Appoints New Chief Commercial Officer and Chief Strategy and Innovation Officer
LYEL

Business Wire

2 years ago

Modivcare Appoints New Chief Commercial Officer and Chief Strategy and Innovation Officer

Q3 Rundown: Darden (NYSE:DRI) Vs Other Sit-Down Dining Stocks
LYEL

StockStory

2 years ago

Q3 Rundown: Darden (NYSE:DRI) Vs Other Sit-Down Dining Stocks

LYEL

Business Wire

2 years ago

BlackRock Closed-End Funds have Repurchased approximately $1.3 Billion of Shares since the Share Repurchase Program’s Inception

ID R&D Introduces Voice Clone Detection for Protection Against Gen AI-based Identity Fraud
LYEL

Business Wire

2 years ago

ID R&D Introduces Voice Clone Detection for Protection Against Gen AI-based Identity Fraud

AAM Showcases Next-Gen Electric Drive Solutions at CES
LYEL

PR Newswire

2 years ago

AAM Showcases Next-Gen Electric Drive Solutions at CES

February Risk Alert: 3 Stocks to Unload Now to Protect Your Portfolio
LYEL

InvestorPlace

2 years ago

February Risk Alert: 3 Stocks to Unload Now to Protect Your Portfolio

Why Shares in Trimble Soared in December
LYEL

Motley Fool

2 years ago

Why Shares in Trimble Soared in December

Hain Celestial Rings NASDAQ Closing Bell
LYEL

CNW Group

2 years ago

Hain Celestial Rings NASDAQ Closing Bell

Corcept (CORT) Surges 5.1%: Is This an Indication of Further Gains?
LYEL

Zacks

2 years ago

Corcept (CORT) Surges 5.1%: Is This an Indication of Further Gains?

4 Top Stocks to Buy From a Promising Security and Safety Services Industry
LYEL

Zacks

2 years ago

4 Top Stocks to Buy From a Promising Security and Safety Services Industry

Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference
LYEL

GlobeNewswire

2 years ago

Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference

At US$96.65, Is It Time To Put John Bean Technologies Corporation (NYSE:JBT) On Your Watch List?
LYEL

Simply Wall St.

2 years ago

At US$96.65, Is It Time To Put John Bean Technologies Corporation (NYSE:JBT) On Your Watch List?

LYEL

Business Wire

2 years ago

Olo to Present at the ICR Conference

Olema Oncology to Present at 42nd Annual J.P. Morgan Healthcare Conference
LYEL

GlobeNewswire

2 years ago

Olema Oncology to Present at 42nd Annual J.P. Morgan Healthcare Conference

Farmland Partners Announces Change to its Board of Directors
LYEL

Business Wire

2 years ago

Farmland Partners Announces Change to its Board of Directors

Should Arko Corp. (NASDAQ:ARKO) Focus On Improving This Fundamental Metric?
LYEL

Simply Wall St.

2 years ago

Should Arko Corp. (NASDAQ:ARKO) Focus On Improving This Fundamental Metric?

Gearing Up for Gains: 3 Top Auto Part Stocks to Buy for 2024
LYEL

InvestorPlace

2 years ago

Gearing Up for Gains: 3 Top Auto Part Stocks to Buy for 2024

ECARX and Black Sesame Technologies Strengthen Partnership to Develop Intelligent Driving Ecosystem
LYEL

GlobeNewswire

2 years ago

ECARX and Black Sesame Technologies Strengthen Partnership to Develop Intelligent Driving Ecosystem

Implied Volatility Surging for Everi Holdings (EVRI) Stock Options
LYEL

Zacks

2 years ago

Implied Volatility Surging for Everi Holdings (EVRI) Stock Options

SunOpta Inc. to Participate in Upcoming Investor Conference
LYEL

Business Wire

2 years ago

SunOpta Inc. to Participate in Upcoming Investor Conference

Companies Like Lyell Immunopharma (NASDAQ:LYEL) Are In A Position To Invest In Growth
LYEL

Simply Wall St.

2 years ago

Companies Like Lyell Immunopharma (NASDAQ:LYEL) Are In A Position To Invest In Growth

Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution
LYEL

PR Newswire

2 years ago

Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution

LSB Industries, Inc.'s (NYSE:LXU) Low P/E No Reason For Excitement
LYEL

Simply Wall St.

2 years ago

LSB Industries, Inc.'s (NYSE:LXU) Low P/E No Reason For Excitement

Smith & Wesson Brands, Inc. (NASDAQ:SWBI) is largely controlled by institutional shareholders who own 52% of the company
LYEL

Simply Wall St.

2 years ago

Smith & Wesson Brands, Inc. (NASDAQ:SWBI) is largely controlled by institutional shareholders who own 52% of the company

Utz Brands to Introduce Long-Term Growth Strategy at 2023 Investor Day
LYEL

Business Wire

2 years ago

Utz Brands to Introduce Long-Term Growth Strategy at 2023 Investor Day

Cassava Sciences Announces Dividend Distribution of Warrants to Shareholders
LYEL

GlobeNewswire

2 years ago

Cassava Sciences Announces Dividend Distribution of Warrants to Shareholders

LYEL

Business Wire

2 years ago

Waffle House Partners with Olo to Lead First Brand-Wide Digital Investment

Rent-A-Center Opens Store in Brooksville, Florida
LYEL

Business Wire

2 years ago

Rent-A-Center Opens Store in Brooksville, Florida

Olo Inc.'s (NYSE:OLO) 27% Jump Shows Its Popularity With Investors
LYEL

Simply Wall St.

2 years ago

Olo Inc.'s (NYSE:OLO) 27% Jump Shows Its Popularity With Investors

Republic Bancorp (NASDAQ:RBCA.A) shareholders have earned a 12% CAGR over the last three years
LYEL

Simply Wall St.

2 years ago

Republic Bancorp (NASDAQ:RBCA.A) shareholders have earned a 12% CAGR over the last three years

Zacks.com featured highlights Axonics, Bel Fuse and Thermon
LYEL

Zacks

2 years ago

Zacks.com featured highlights Axonics, Bel Fuse and Thermon

Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of Melanoma
LYEL

GlobeNewswire

2 years ago

Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of Melanoma

Share on Social Networks: